The United States Neuroendocrine Tumor Treatment Market is witnessing significant growth, supported by increasing diagnosis of neuroendocrine tumors, advanced oncology infrastructure, and rising adoption of targeted and personalized treatment strategies. The country has a strong ecosystem of specialized cancer centers, pharmaceutical companies, and research institutions involved in developing...